Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis
Recruiting · NCT07375433 · Observational (researchers observe without assigning treatment) · Lead sponsor: National Medical Research Center for Therapy and Preventive Medicine
View the official record on ClinicalTrials.gov →Interventions studied
6-Minute Walk Test (6MWT)Body plethysmographyEchocardiographySpirometrylaboratory biomarker analysis
What this trial is about
Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.
Who can take part
Age range
50 Years to 70 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Verified diagnosis of COPD;
- Patients hospitalized with COPD;
- Citizenship of the Russian Federation;
- Patients aged 50 to 70 years;
- Patient consent to participate in the study.
Exclusion criteria
- Lack of Russian Federaion citizenship;
- Patient's refusal to participate in the study;
- Any chronic diseases, other than COPD, that affect the prognosis, in the acute and/or decompensated stage;
- Mental disorders.
Where it is running
2 locations listed.
- Kazan State Medical University - Kazan', Russia
- National Medical Research Center for Therapy and Preventive Medicine - Moscow, Russia